Results 181 to 190 of about 2,578,631 (261)

Comparative field‐scale assessment of TLUD and Kon‐Tiki biochar systems: agronomic performance and net CO2e‐based techno‐economics

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Post‐harvest agricultural residues in Latin America are commonly underutilized, leading to greenhouse gas emissions and lost opportunities for bio‐based value creation. This study tests the hypothesis that decentralized, farmer‐scale pyrolysis technologies can deliver comparable agronomic benefits while exhibiting distinct techno‐economic and ...
Juan F. Saldarriaga, Thomas Käslin, Enara Fernández, Maider Amutio, Gartzen López, Laura Santamaria, Nausika Querejeta, Julián E. López   +7 more
wiley   +1 more source

Variations in Regulated Cannabis Sales Conditions and Their Effect on Purchase Behaviour: Findings from an Observational Study.

Eur Addict Res
Heckel N, Buschner M, Engeli EJE, Dürler P, Havelka EM, Haas M, Herdener M, Nordt C.   +7 more
europepmc   +1 more source

Design, comparison and selection of two competition incentive mechanisms. [PDF]

PLoS One
Li D, Wang H, Ye J.
europepmc   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Minimum Legal Sales Age for e-Cigarettes: a Qualitative Study on the Implementation of Model Policy Components. [PDF]

Nicotine Tob Res
Chadwick G, Kruse GR, Stover M, Reitan CA, Mendez VL, Kahl HM, Levy DE.   +6 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Sales characteristics of Pokémon trading cards: A prospective one-year field study. [PDF]

PLoS One
Heck J, Schormann S, Krichevsky B, Groh A, Pape T, Schröder S, Glahn A, Schumacher C, Westhoff MS.   +8 more
europepmc   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Sun-Exposure-Related Healthcare Use: Analysis of Pharmacy Sales, SOS Médecins Records, and Emergency Department Visits: PRISME Study, Occitanie, Southern France, 2019-2022. [PDF]

Int J Environ Res Public Health
Simac L, Catelinois O, Yahiaoui Y, Golliot F, Mouly D.   +4 more
europepmc   +1 more source

Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficiencies

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Children with primary immunodeficiency (PID) and secondary antibody deficiency (SAD) often require immunoglobulin replacement therapy due to low plasma immunoglobulin G (IgG) levels and recurrent infections. Existing pharmacokinetic models for immunoglobulin in PID patients predominantly focus on adults, with limited attention to ...
Iek Leng Cheng, Zhong Hui Huang, Austen Worth, Claire Booth, Joseph F. Standing   +4 more
wiley   +1 more source